Generated July 24, 2026 at 8:33 PM ET
· Covers July 24 trading day
· 8 of 209 ready 8-Ks selected
· AI-assisted overview
The day's filings were dominated by major corporate actions: Berkshire Hathaway completed its $6.8B acquisition of Taylor Morrison Home Corp, and Matador Resources agreed to acquire Paloma Permian for $1.275B cash plus Ridge Runner acreage. In regulatory news, FibroBiologics received a Nasdaq delisting notice for bid price non-compliance, while Outlook Therapeutics gained FDA approval for LYTENAVA for wet AMD. Chegg received a second NYSE delisting notice, and Acura Pharmaceuticals warned of possible shutdown without additional funding. Additionally, QVC Inc.'s prepackaged Chapter 11 plan was confirmed by the bankruptcy court, canceling all equity for no consideration.
FBLG
FibroBiologics, Inc.
regulatory
negative
materiality 0.90
July 24, 2026, 4:05 PM ET
FibroBiologics receives Nasdaq delisting notice for bid price non-compliance
- Nasdaq Staff Determination on July 22, 2026: bid price below $1.00 for 30 consecutive business days (June 8–July 21, 2026).
- Company ineligible for 180-day cure period due to reverse stock split within prior year (Listing Rule 5810(c)(3)(A)(iv)).
- Delisting scheduled for July 31, 2026 unless appeal requested by July 29, 2026; company intends to request hearing.
TMHC
Taylor Morrison Home Corp
M&A
positive
materiality 1.00
July 24, 2026, 4:00 PM ET
Berkshire Hathaway completes $6.8B acquisition of Taylor Morrison at $72.50/share
- Total equity value ~$6.8B, enterprise value ~$8.5B; shareholders received $72.50 per share in cash.
- Taylor Morrison CEO Sheryl Palmer will continue to lead and integrate with Berkshire's Clayton Properties Group.
- Combined entity delivered ~23,000 site-built home closings in 2025, operating in 21 states and 52 markets, becoming 4th largest US homebuilder.
OTLK
Outlook Therapeutics, Inc.
regulatory
positive
materiality 0.90
July 24, 2026, 5:01 PM ET
Outlook Therapeutics receives FDA approval for LYTENAVA (bevacizumab-vikg) for wet AMD
- LYTENAVA is the first and only FDA-approved ophthalmic bevacizumab for wet AMD in the US.
- Company anticipates 12 years of Reference Product Exclusivity under the BPCIA.
- US anti-VEGF retina market estimated at ~$8.5B annually; commercial launch expected before year-end.
regulatory
negative
materiality 0.80
July 24, 2026, 4:15 PM ET
Chegg receives second NYSE delisting notice for share price below $1.00
- NYSE notified Chegg on July 24, 2026 that average closing price was below $1.00 over 30 trading days ending July 23, 2026.
- This is a second notice; a prior notice from December 2025 was cured in May 2026.
- Chegg has a six-month cure period and may consider a reverse stock split to regain compliance.
—
ACURA PHARMACEUTICALS, INC
debt
negative
materiality 0.90
July 24, 2026, 4:15 PM ET
Acura receives $200K loan from AD Pharma; warns of possible shutdown without more funding by mid-August
- New $200K loan from Abuse Deterrent Pharma increases principal to $10.9M, bearing 5.25% interest.
- Accrued interest ~$1.2M as of July 17, 2026; overdue amounts bear 7.5% interest.
- Without additional financing by mid-August 2026, company will scale back operations, furlough/lay off employees, or seek bankruptcy.
M&A
positive
materiality 0.70
July 24, 2026, 6:03 AM ET
SoundHound receives final foreign investment clearance for LivePerson acquisition
- Received Bulgarian foreign investment clearance on July 20, 2026, the last required regulatory approval for the LivePerson merger.
- Prior clearances obtained from Italy (June 25), Canada (June 25), Germany (June 29), and UK (July 1).
- All regulatory approval conditions for the merger are now satisfied.
MTDR
Matador Resources Co
M&A
positive
materiality 0.90
July 24, 2026, 7:00 AM ET
Matador to acquire Paloma Permian for $1.275B cash and Ridge Runner acreage; Woodford well test exceeds 2,200 BOE/d
- Paloma Acquisition: $1.275B cash for 16,235 net acres in Eddy/Lea Counties, NM; adds ~11,100 BOE/d (57% oil) and 55 MMBOE proved reserves.
- Ridge Runner Acquisition: adds ~50,000 contiguous net acres in Woodford play; 150+ net operated locations acquired at ~$1.3M per location.
- Rae's Creek Woodford well tested at >2,200 BOE/d (72% oil); 60-day cumulative oil production 20% above average Woodford wells in Texas.
other material
negative
materiality 1.00
July 24, 2026, 5:05 PM ET
Bankruptcy Court confirms QVC Group's prepackaged Chapter 11 plan; equity canceled for no consideration
- On July 20, 2026, Bankruptcy Court entered order confirming Second Amended Joint Prepackaged Plan of Reorganization.
- All existing common and preferred equity interests will be canceled for no consideration on the Effective Date.
- RCF and QVC Notes claimholders receive pro rata share of QVC Funded Debt Plan Consideration (cash, Takeback Debt, and 100% of new equity).